Teleflex lands FDA win for Arrow UltraQuik needles
January 25, 2013 by MassDevice staff
Medical device company Teleflex touts 510(k) clearance for its Arrow UltraQuik peripheral nerve block needles.
Limerick, Pa.-based Teleflex (NYSE:TFX) won FDA clearance for the latest in its line of peripheral nerve block needles, the Arrow UltraQuik.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Medtronic hits 52-week high on Q4, FY2013 results
Investors sent Medtronic shares to a 52-week high yesterday after the world's largest medical device...
MassDevice.com +3 | The top 3 med-tech stories for May 21, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Maquet acquires LAAx and its TigerPaw II heart implant
Getinge Group's medical device subsidiary Maquet Cardiovascular buys LAAx and its TigerPaw heart...
EuroPCR: Medtronic's renal denervation looks good in the real world
Medical device giant Medtronic unveils a 1st look from its global Symplicity renal denervation...
Stentys enrolls 1st patient in U.S. stent trial
Stentys launches a clinical trial aimed at backing a pre-market approval application with the FDA for...
